Please login to the form below

Not currently logged in
Email:
Password:

Icon to set up translational medicine centre in the UK

Expands early phase research presence at new Manchester site

Contract research organisation Icon is expanding its early phase research presence in the UK and setting up a new translational medicine centre.

Based in the Citylabs biomedical centre on the former site of the Manchester Royal Eye Hospital, Icon's Centre of Excellence for Translational Medicine will occupy a 40,000 sq ft site and is due to open before the end of 2013.

At this time Icon will also move the phase I operations of its hospital-based clinical pharmacology unit to Citylabs from its current base on the Manchester Royal Infirmary Campus.

President of Icon Development Solutions Dr Mario Rocci said: “We are pleased to be expanding our early phase development services through the establishment of a Centre of Excellence for Translational Medicine in Citylabs.

“This expansion will enable Icon to increase the capacity of its Clinical Pharmacology Unit in Manchester as well as the scientific services that are essential in providing a world class offering.”

Translational research is a way of conducting scientific research 'from bench to bedside' and also 'from bedside to bench', to ensure the results will be applicable to the relevant patient population 

Along with Icon's Translational Medicine Research Centre, Citylabs be home to a number of other health organisations, including the Central Manchester University Hospitals NHS Foundation Trust, The University of Manchester and commercial research organisations.

Mike Deegan, chief executive of Central Manchester University Hospitals NHS Foundation Trust, said: “This exciting development supports our progress to be the leading hospital for research and patient care in England and Citylabs will strengthen our capability to support the development of new medicines and diagnostics for our patients.

“We are pleased that Icon, who is one of the leaders in early phase trials, is expanding into Citylabs which will help our patients to get early access to leading edge new treatments.”

8th August 2012

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

Harnessing the power of core elements to optimise market access
This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...
So how do you really engage with patients?
The most valuable insights from patient engagement are the most unexpected ones. Simple things, which may seem unimportant to you, may be the key to making patients’ lives easier and...
data
Avoiding data pitfalls in clinical research
Genomics sequencing and sensors will present new challenges...

Infographics